IMPORTANT: Read the Prep & Injection Guide for proper reconstitution, syringe sizing, and injection protocols. Mistakes here can compromise your research.
Cardiogen (Inj)
Cardiogen is a tetrapeptide bioregulator (Ala-Glu-Asp-Arg) developed by the St. Petersburg Institute of Bioregulation and Gerontology in Russia. It is classified as a tissue-specific peptide bioregulator designed for cardiac tissue, derived from heart proteins. Research suggests it supports cardiomyocyte function, reduces age-related cardiac decline, and may improve heart muscle performance in aging subjects.
Dosing Protocols
Typical research dosing: 5–10 mcg subcutaneously once daily for 10 days. Repeat cycles 2–3 times per year. Some protocols use 1–2 courses annually for anti-aging cardiac support. Based on Russian clinical research protocols from the Khavinson Institute.
Benefits
- Supports cardiomyocyte protein synthesis and function
- May reduce age-related decline in cardiac output
- Studied for cardiac ischemia and post-infarction recovery
- Anti-aging effects on heart tissue
- Improves cardiac bioelectric activity in research models
- Well-tolerated with minimal systemic side effects
- May work synergistically with other peptide bioregulators
Mechanism of Action
Cardiogen is a short tetrapeptide (Ala-Glu-Asp-Arg) that functions as a gene expression regulator in cardiac tissue. Like other peptide bioregulators developed by the Khavinson group, it is believed to interact with gene promoter regions in cardiomyocytes, upregulating expression of proteins involved in cellular repair, energy metabolism, and contractility. This epigenetic-like mechanism distinguishes bioregulator peptides from receptor-mediated peptides.
Side Effects
- Generally very well tolerated
- Mild injection site reactions
- No significant systemic side effects reported in available research
Side Effect Management
Peptide bioregulators like Cardiogen are among the best-tolerated research compounds. Injection site rotation is recommended. No known significant drug interactions based on current research.
Contraindications
- Known hypersensitivity to the peptide
- Pregnancy and lactation (insufficient data)
Research Use Only. All information is for educational purposes. Not medical advice. Consult a licensed healthcare provider before making health decisions.
Research Use Only. All information on this page is for educational purposes only and is not medical advice. PepSherpa does not sell peptides. Consult a licensed healthcare provider before making any health decisions. Many of the studies cited are preclinical (animal/in-vitro).
